MedCity News June 8, 2023
Appropriate Medicare reimbursement of high-intensity focused ultrasound for prostate disease is a significant development for the treatment for men 65 years and older today.
Too often in healthcare, innovations are reserved only for the affluent and those who can afford to pay out of pocket. However, in one area, we’ve recently seen an improvement that will hopefully begin to bridge the gap to expand access to new therapies.
What is this promising development? Medicare recently decided to improve reimbursement for hospitals performing non-invasive high-intensity focused ultrasound (HIFU) to treat prostate disease. By covering the cost of the procedure, hospitals are now more likely to offer HIFU, and the mix of patients who will be able to access this non-invasive therapy...
Today's Sponsors
Today's Sponsor